What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
David A. Luckenbaugh mainly focuses on Bipolar disorder, Antidepressant, Psychiatry, Internal medicine and Anesthesia.
His Antidepressant research integrates issues from Major depressive disorder, Antagonist and Hippocampal formation.
David A. Luckenbaugh combines subjects such as Prospective cohort study, Clinical psychology and Risk factor with his study of Psychiatry.
His Internal medicine research incorporates elements of Gastroenterology, Endocrinology, Mood disorders and Brain mapping.
The various areas that David A. Luckenbaugh examines in his Anesthesia study include NMDA receptor, Randomized controlled trial and Riluzole.
His work investigates the relationship between Ketamine hydrochloride and topics such as Esketamine that intersect with problems in Crossover study.
His most cited work include:
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression (2287 citations)
- A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression (669 citations)
- Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. (523 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Bipolar disorder, Psychiatry, Internal medicine, Major depressive disorder and Depression.
His work is dedicated to discovering how Bipolar disorder, Mood are connected with Bipolar I disorder and other disciplines.
In general Psychiatry, his work in Anxiety is often linked to Suicidal ideation linking many areas of study.
His Internal medicine research includes themes of Crossover study, Endocrinology, Neuroscience and Gastroenterology.
His Major depressive disorder research includes elements of Anhedonia, Working memory, Ketamine, Clinical psychology and Antidepressant.
His biological study spans a wide range of topics, including Anesthesia and Pharmacology.
He most often published in these fields:
- Bipolar disorder (37.77%)
- Psychiatry (38.83%)
- Internal medicine (34.04%)
What were the highlights of his more recent work (between 2012-2020)?
- Major depressive disorder (32.45%)
- Ketamine (22.87%)
- Psychiatry (38.83%)
In recent papers he was focusing on the following fields of study:
David A. Luckenbaugh mainly investigates Major depressive disorder, Ketamine, Psychiatry, Bipolar disorder and Anesthesia.
His Major depressive disorder study is concerned with the larger field of Depression.
The study incorporates disciplines such as NMDA receptor, Anterior cingulate cortex, Major depressive episode and Antidepressant, Antidepressant efficacy in addition to Ketamine.
His Anxiety and Mood study in the realm of Psychiatry connects with subjects such as Suicidal ideation.
His Bipolar disorder research is multidisciplinary, incorporating perspectives in Early onset, Lithium, Crossover study and Clinical psychology.
His studies examine the connections between Anesthesia and genetics, as well as such issues in Riluzole, with regards to Electroconvulsive therapy, GRIN1 and GRIN2B.
Between 2012 and 2020, his most popular works were:
- A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. (173 citations)
- Do the dissociative side effects of ketamine mediate its antidepressant effects (149 citations)
- Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety (137 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
The scientist’s investigation covers issues in Major depressive disorder, Ketamine, Antidepressant, Psychiatry and Internal medicine.
His studies deal with areas such as Anterior cingulate cortex and Brain mapping as well as Ketamine.
His Antidepressant study integrates concerns from other disciplines, such as Anesthesia, NMDA receptor, Dissociative, Pharmacology and Receptor antagonist.
His Anesthesia study combines topics from a wide range of disciplines, such as Lanicemine, Randomized controlled trial and Psychotomimetic.
His study on Depression, Anxiety and Bipolar disorder is often connected to Suicidal ideation as part of broader study in Psychiatry.
As a part of the same scientific family, David A. Luckenbaugh mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Infralimbic cortex and Mood.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
